MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-07-2025
LeMaitre Vascular Cash Conversion Cycle 2011-2026 | LMAT
Annual Cash Conversion Cycle LeMaitre Vascular
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28.7 | 23.3 | 30.2 | 30 | 30.6 | 364 | 329 | 268 | 273 | 265 | 306 | 286 | 284 | 201 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 364 | 23.3 | 194 |
Quarterly Cash Conversion Cycle LeMaitre Vascular
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26.2 | 34.1 | 41.9 | 43.1 | - | - | 26.7 | 29.7 | 28.3 | - | 14.2 | 16.2 | 32.1 | 45.2 | 30.3 | 30.7 | 31.7 | 47.5 | 33.1 | 43.9 | 31.3 | 50.1 | 25.4 | 25.4 | 29.8 | 50.5 | 36.5 | 33.4 | 34 | 52.3 | 165 | 263 | 53.3 | 51.7 | 51.9 | 53.8 | 56.7 | - | 57.4 | 54.9 | 54.8 | - | 56.3 | 54.3 | 58.3 | - | 63.2 | 60.6 | 58.2 | - | 60.5 | 57.5 | 57.6 | - | 53.5 | 51.6 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 263 | 14.2 | 50.4 |
Cash Conversion Cycle of other stocks in the Medical instruments industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
253 K | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
262 | $ 19.94 | 1.45 % | $ 10.2 B | USA |
 |
Luminex Corporation
LMNX
|
18.9 | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
95.3 | - | -9.52 % | $ 20.6 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
204 | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
400 | - | -1.18 % | $ 3.4 B | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
11.9 | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
194 | - | -0.02 % | $ 16.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
266 | $ 8.05 | -2.07 % | $ 162 M | USA |
 |
Alcon
ALC
|
134 | $ 80.14 | 1.44 % | $ 40.4 B |  Schweiz |
 |
AtriCure
ATRC
|
185 | $ 37.41 | 2.77 % | $ 1.76 B | USA |
 |
electroCore
ECOR
|
2.97 | $ 6.53 | 3.82 % | $ 36 K | USA |
 |
ICU Medical
ICUI
|
143 | $ 148.7 | 0.28 % | $ 3.63 B | USA |
 |
AngioDynamics
ANGO
|
124 | $ 10.21 | 1.37 % | $ 417 M | USA |
 |
InfuSystem Holdings
INFU
|
24.9 | $ 8.74 | 2.7 % | $ 180 M | USA |
 |
The Cooper Companies
COO
|
210 | $ 81.74 | 0.05 % | $ 16.3 B | USA |
 |
Haemonetics Corporation
HAE
|
217 | $ 76.43 | -3.0 % | $ 3.85 B | USA |
 |
Harvard Bioscience
HBIO
|
208 | $ 0.57 | -2.96 % | $ 24.2 M | USA |
 |
Glaukos Corporation
GKOS
|
170 | $ 103.94 | -5.75 % | $ 5.03 B | USA |
 |
Repro Med Systems
KRMD
|
149 | $ 5.56 | -3.81 % | $ 254 M | USA |
 |
Isoray
ISR
|
173 | - | 0.03 % | $ 108 M | USA |
 |
iRhythm Technologies
IRTC
|
58.7 | $ 163.14 | 4.95 % | $ 5.09 B | USA |
 |
Masimo Corporation
MASI
|
83.7 | $ 137.72 | 6.07 % | $ 7.34 B | USA |
 |
Merit Medical Systems
MMSI
|
171 | $ 81.8 | 0.89 % | $ 4.76 B | USA |
 |
Intuitive Surgical
ISRG
|
208 | $ 547.88 | -2.48 % | $ 195 B | USA |
 |
Microbot Medical
MBOT
|
-52.9 | $ 2.16 | 1.89 % | $ 22 M |  Israel |
 |
Nephros
NEPH
|
161 | $ 4.4 | -0.51 % | $ 45.7 M | USA |
 |
Milestone Scientific
MLSS
|
545 | $ 0.29 | 0.99 % | $ 23.1 M | USA |
 |
NeuroMetrix
NURO
|
357 | - | 5.05 % | $ 9.02 M | USA |
 |
OraSure Technologies
OSUR
|
167 | $ 2.69 | 3.27 % | $ 200 M | USA |
 |
Envista Holdings Corporation
NVST
|
79.4 | $ 24.14 | 3.92 % | $ 4.16 B | USA |
 |
Pro-Dex
PDEX
|
193 | $ 40.05 | -0.72 % | $ 132 M | USA |
 |
Predictive Oncology
POAI
|
-241 | $ 7.28 | 1.0 % | $ 39.7 M | USA |
 |
Pulse Biosciences
PLSE
|
36.5 | $ 14.3 | 1.06 % | $ 687 M | USA |
 |
Becton, Dickinson and Company
BDX
|
110 | $ 207.32 | 2.88 % | $ 59.6 B | USA |
 |
Repligen Corporation
RGEN
|
272 | $ 161.81 | -3.29 % | $ 9.02 M | USA |
 |
ResMed
RMD
|
167 | $ 259.06 | 1.71 % | $ 37.8 B | USA |
 |
STERIS plc
STE
|
112 | $ 264.04 | 1.58 % | $ 26 B | USA |
 |
BioLife Solutions
BLFS
|
37.9 | $ 24.28 | 1.59 % | $ 1.12 B | USA |
 |
Stereotaxis
STXS
|
212 | $ 2.76 | 2.8 % | $ 223 M | USA |
 |
Retractable Technologies
RVP
|
250 | $ 0.72 | -2.7 % | $ 21.6 M | USA |
 |
STAAR Surgical Company
STAA
|
26 | $ 21.52 | 1.82 % | $ 1.06 B | USA |
 |
Utah Medical Products
UTMD
|
280 | $ 58.97 | 0.7 % | $ 214 M | USA |
 |
Teleflex Incorporated
TFX
|
183 | $ 103.33 | -0.54 % | $ 4.84 B | USA |
 |
West Pharmaceutical Services
WST
|
98.9 | $ 276.83 | 1.84 % | $ 20.2 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
63.9 | $ 12.38 | 2.08 % | $ 2.52 B | USA |